AstraZeneca PLC
Breztri Aerosphere
asthma
Resolved
70days ago
Approval decision · Apr 28, 2026
What's at stake
A final FDA approval decision on Breztri Aerosphere for asthma is expected Apr 28, 2026.
Primary source
· SEC 6-K
verified 13h ago
“Breztri approved in the US for asthma as first and only triple therapy for patients 12 years of age and older”